The best indicator for Gilead Sciences (GILD)
We backtested 366 indicators across daily, weekly and hourly charts on real Gilead Sciences (GILD) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Keltner Mean-Reversion
On the daily chart, this is the strongest risk-adjusted edge we found for Gilead Sciences (GILD) over ~34.3 years — trailing buy-and-hold by 4.2% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Gilead Sciences (GILD) — trailing buy-and-hold by 5.0% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Keltner Mean-Reversion ✓ | Daily | 13.8% | 0.77 | -32.8% | 75.0% | 88 | -4.2% |
| 2 | MA Envelope ✓ | Daily | 18.6% | 0.71 | -61.4% | 68.9% | 286 | 0.6% |
| 3 | Connors RSI ✓ | Daily | 16.3% | 0.7 | -52.9% | 61.3% | 408 | -1.7% |
| 4 | Projection Bands ✓ | Daily | 16.8% | 0.69 | -55.3% | 67.7% | 310 | -1.2% |
| 5 | Demand Index ✓ | Weekly | 16.5% | 0.68 | -50.1% | 68.5% | 89 | -1.1% |
| 6 | Pivot Points (Standard) ✓ | Weekly | 15.2% | 0.67 | -42.5% | 60.7% | 244 | -2.4% |
| 7 | VWAP Bands ✓ | Daily | 13.3% | 0.66 | -33.3% | 69.5% | 141 | -4.7% |
| 8 | Murrey Math Lines ✓ | Daily | 16.1% | 0.66 | -51.0% | 80.2% | 96 | -1.9% |
| 9 | Order-Flow Reversion ✓ | Daily | 12.8% | 0.66 | -37.9% | 73.4% | 124 | -5.3% |
| 10 | Bollinger Mean-Reversion ✓ | Daily | 13.3% | 0.64 | -43.7% | 69.9% | 143 | -4.8% |
| 11 | Pivot Points (Standard) ✓ | Daily | 14.9% | 0.64 | -48.4% | 50.2% | 1226 | -3.1% |
| 12 | Fibonacci Bands ✓ | Daily | 13.3% | 0.64 | -43.7% | 69.9% | 143 | -4.8% |
| 13 | MA Envelope ✓ | Weekly | 15.1% | 0.64 | -51.1% | 74.4% | 90 | -2.5% |
| 14 | Markov Regime ✓ | Weekly | 17.6% | 0.62 | -62.2% | 59.2% | 76 | 0.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Gilead Sciences (GILD), Keltner Mean-Reversion on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.